Upregulation of Insulin-like Growth Factor-1 Receptor Expression in Pretibial Myxedema: Evidence for a Treatment Target

被引：0
作者：
Walsh, Hannah L. [1 ]
Shoji, Marissa K. [2 ]
Gallo, Ryan A. [1 ]
Mervis, Joshua S. [3 ]
Maeng, Michelle M. [4 ]
Elgart, George W. [3 ]
Kirsner, Robert S. [3 ]
Wester, Sara T. [2 ]
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL USA
[2] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, 900 NW 17th St, Miami, FL 33136 USA
[3] Univ Miami, Miller Sch Med, Dr Phillip Frost Dept Dermatol & Cutaneous Surg, Miami, FL USA
[4] Yale Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT USA
来源：
AMERICAN JOURNAL OF DERMATOPATHOLOGY | 2024年 / 46卷 / 03期
关键词：
thyroid eye disease; pretibial myxedema; insulin-like growth factor-1; insulin-like growth factor 1 receptor; immunohistochemistry; SKIN;
D O I：
10.1097/DAD.0000000000002597
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：153 / 154
页数：2
相关论文
共 10 条
  • [1] Extrathyroidal manifestations of Graves' disease: a 2014 update
    Bartalena, Luigi
    Fatourechi, Vahab
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (08): : 691 - 700
  • [2] Clinical features of Graves' ophthalmopathy in an incidence cohort
    Bartley, GB
    Fatourechi, V
    Kadrmas, EF
    Jacobsen, SJ
    Ilstrup, DM
    Garrity, JA
    Gorman, CA
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (03) : 284 - 290
  • [3] Teprotumumab for the Treatment of Active Thyroid Eye Disease
    Douglas, R. S.
    Kahaly, G. J.
    Patel, A.
    Sile, S.
    Thompson, E. H. Z.
    Perdok, R.
    Fleming, J. C.
    Fowler, B. T.
    Marcocci, C.
    Marino, M.
    Antonelli, A.
    Dailey, R.
    Harris, G. J.
    Eckstein, A.
    Schiffman, J.
    Tang, R.
    Nelson, C.
    Salvi, M.
    Wester, S.
    Sherman, J. W.
    Vescio, T.
    Holt, R. J.
    Smith, T. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (04) : 341 - 352
  • [4] Fatourechi V, 2012, BEST PRACT RES CL EN, V26, P551, DOI [10.1016/j.beem.2012.07.002, 10.1016/j.beem.2011.10.001]
  • [5] The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: Correlation of increased expression with epidermal hyperplasia
    Hodak, E
    Gottlieb, AB
    Anzilotti, M
    Krueger, JG
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (03) : 564 - 570
  • [6] Teprotumumab as a novel treatment for pretibial myxoedema
    Mervis, Joshua S.
    Maeng, Michelle M.
    Kirsner, Robert S.
    Wester, Sara T.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (05) : 795 - 797
  • [7] The role of IGF-I in human skin and its appendages: Morphogen as well as mitogen?
    Rudman, SM
    Philpott, MP
    Thomas, GA
    Kealey, T
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (06) : 770 - 777
  • [8] Epidermal insulin/IGF-1 signalling control interfollicular morphogenesis and proliferative potential through Rac activation
    Stachelscheid, Heike
    Ibrahim, Hady
    Koch, Linda
    Schmitz, Annika
    Tscharntke, Michael
    Wunderlich, F. Thomas
    Scott, Jeanie
    Michels, Christian
    Wickenhauser, Claudia
    Haase, Ingo
    Bruening, Jens C.
    Niessen, Carien M.
    [J]. EMBO JOURNAL, 2008, 27 (15) : 2091 - 2101
  • [9] Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor I receptors: A tale of two antigens implicated in Graves' disease
    Tsui, Shanli
    Naik, Vibha
    Hoa, Neil
    Hwang, Catherine J.
    Afifiyan, Nikoo F.
    Hikim, Amiya Sinha
    Gianoukakis, Andrew G.
    Douglas, Raymond S.
    Smith, Terry J.
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 181 (06) : 4397 - 4405
  • [10] Teprotumumab for non-inflammatory thyroid eye disease (TED): evidence for increased IGF-1R expression
    Ugradar, Shoaib
    Shi, Lu
    Wang, Yao
    Mester, Tunde
    Yang, Huasheng
    Douglas, Raymond S.
    [J]. EYE, 2021, 35 (09) : 2607 - 2612
1